High titre vectors for targeted expression of multiple genes

High titre vectors for targeted expression of multiple genes

Bibliografski detalji
Glavni autori:	Darling, D, Gaken, J, Nesbeth, D, Chan, L, Hardwick, N, Mackey, T, Galea-Lauri, J, Vyakarnam, A, Mufti, G, Kemeny, M, Farzaneh, F
Format:	Journal article
Izdano:	2004

Slični predmeti

Monocistronic high titre vectors for targeted expression of multiple therapeutic genes
od: Darling, D, i dr.
Izdano: (2004)

Low-speed centrifugation of retroviral vectors absorbed to a particulate substrate: a highly effective means of enhancing retroviral titre.
od: Darling, D, i dr.
Izdano: (2000)

IL-2/B7.1 fusagene transduction of AML blasts by a self-inactivating lentiviral vector stimulates T cell responses in vitro: A strategy to generate whole cell vaccines for AML
od: Chan, L, i dr.
Izdano: (2004)

IL-2/B7.1 (CD80) fusagene transduction of AML blasts by a self-inactivating lentiviral vector stimulates T cell responses in vitro: a strategy to generate whole cell vaccines for AML.
od: Chan, L, i dr.
Izdano: (2005)

Conjugation of lentivirus to paramagnetic particles via nonviral proteins allows efficient concentration and infection of primary acute myeloid leukemia cells.
od: Chan, L, i dr.
Izdano: (2005)

Tumour cells expressing B7.1 costimulatory molecule: Are these better targets for NK cells?
od: GaleaLauri, J, i dr.
Izdano: (1996)

Fusagene vectors: A novel strategy for the expression of multiple genes from a single cistron
od: Gaken, J, i dr.
Izdano: (1998)

Fusagene vectors: a novel strategy for the expression of multiple genes from a single cistron.
od: Gäken, J, i dr.
Izdano: (2000)

Fusagene vectors: a novel strategy for the expression of multiple genes from a single cistron
od: Gaken, J, i dr.
Izdano: (2001)

Prospects of immune gene therapy for cancer
od: Hardwick, N, i dr.
Izdano: (2004)

A polycistronic retroviral vector encoding hB7-1 (CD80) and hIL-2 for ex vivo cancer gene therapy.
od: Kuiper, M, i dr.
Izdano: (1996)

An immune edited tumour versus a tumour edited immune system: Prospects for immune therapy of acute myeloid leukaemia.
od: Chan, L, i dr.
Izdano: (2006)

Induction of tumour rejection by autologous and allogeneic tumour cells expressing B7.1 and IL-2.
od: Hirst, W, i dr.
Izdano: (1996)

Induction of tumour rejection by B7.1 and IL-2 expressing tumour cells
od: Gaken, J, i dr.
Izdano: (1997)

Expression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cells.
od: Galea-Lauri, J, i dr.
Izdano: (1999)

Novel costimulators in the immune gene therapy of cancer.
od: Galea-Lauri, J, i dr.
Izdano: (1996)

Streptavidin paramagnetic particles provide a choice of three affinity-based capture and magnetic concentration strategies for retroviral vectors.
od: Hughes, C, i dr.
Izdano: (2001)

Eliciting cytotoxic T lymphocytes against acute myeloid leukemia-derived antigens: evaluation of dendritic cell-leukemia cell hybrids and other antigen-loading strategies for dendritic cell-based vaccination.
od: Galea-Lauri, J, i dr.
Izdano: (2002)

In vitro immune modulation by antibodies coupled to tumour cells.
od: Darling, D, i dr.
Izdano: (1997)

Affinity mediated magnetic concentration of retroviral vectors
od: Hughes, C, i dr.
Izdano: (2001)

Influence of interleukin-4 on the phenotype and function of bone marrow-derived murine dendritic cells generated under serum-free conditions.
od: Wells, J, i dr.
Izdano: (2005)

Enhancing titres of therapeutic viral vectors using the transgene repression in vector production (TRiP) system
od: H. E. Maunder, i dr.
Izdano: (2017-03-01)

Dendritic cell/tumour fusions are more efficient at eliciting MHC class I-restricted Ag-specific CTL responses when compared to antigen-pulsed dendritic cells
od: Galea-Lauri, J, i dr.
Izdano: (2001)

Irradiated NC adenocarcinoma cells transduced with both B7.1 and interleukin-2 induce CD4+-mediated rejection of established tumors.
od: Gaken, J, i dr.
Izdano: (1997)

Rapid determination of rSIV.F/HN lentiviral vector titre
od: Conway, CC, i dr.
Izdano: (2020)

Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination.
od: Galea-Lauri, J, i dr.
Izdano: (2004)

Document sans titre
od: Romané Landaeta Sepúlveda
Izdano: (2010-01-01)

Document sans titre
od: Frédérique Langue
Izdano: (2008-03-01)

[Poème sans titre]
od: Eduardo Chirinos
Izdano: (2010-12-01)

Document sans titre
od: Yves Laberge
Izdano: (2010-06-01)

Document sans titre
Izdano: (2024-03-01)

Document sans titre
od: Cristina Álvares, i dr.
Izdano: (2023-01-01)

Document sans titre
od: Laurent Brassous
Izdano: (2023-10-01)

Document sans titre
od: Ângela Lacerda-Nobre, i dr.
Izdano: (2023-04-01)

Document sans titre
od: Toumi Farid, i dr.
Izdano: (2019-06-01)

La marque du Titre
od: Amalia Chaverri F.
Izdano: (2015-08-01)

Recent titles/Titres Récents
od: The Historical Review La Revue Historique
Izdano: (2017-02-01)

A comparison of CTL induction by different methods of antigen loading of monocyte-derived dendritic cells
od: Galea-Lauri, J, i dr.
Izdano: (2001)

Serum bactericidal and inhibitory titres in the management of melioidosis.
od: Simpson, A, i dr.
Izdano: (2000)

Efficient retroviral infection of mammalian cells is blocked by inhibition of poly(ADP-ribose) polymerase activity.
od: Gäken, J, i dr.
Izdano: (1996)